Chlamydia Rapid Test Device (Swab/Urine) |
173-8537306 |
Abbott |
20 Tests/Kit |
EUR 300 |
Cotinine Assay Laboratories manufactures the alere cotinine test device reagents distributed by Genprice. The Alere Cotinine Test Device reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cotinine assay. Other Alere products are available in stock. Specificity: Alere Category: Cotinine Group: Test Device
(-)-Cotinine |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Test Device information
Cotinine-3 (HRP) |
abx080005-1ml |
Abbexa |
1 ml |
EUR 1195.2 |
|
Cotinine-4 (HRP) |
abx080006-1ml |
Abbexa |
1 ml |
EUR 1195.2 |
|
Cotinine-4 (BSA) |
abx080056-1mg |
Abbexa |
1 mg |
EUR 1111.2 |
|
Cotinine antibody |
20-1713 |
Fitzgerald |
100 ul |
EUR 760.8 |
Description: Sheep polyclonal Cotinine antibody |
Cotinine Antibody |
20-1733 |
Fitzgerald |
1 mg |
EUR 346.8 |
Description: Purified Polyclonal Cotinine Antibody |
Cotinine Antibody |
abx020997-1mg |
Abbexa |
1 mg |
EUR 811.2 |
|
Cotinine Antibody |
abx022797-1mg |
Abbexa |
1 mg |
EUR 811.2 |
|
Cotinine Antibody |
abx022799-1mg |
Abbexa |
1 mg |
EUR 844.8 |
|
Cotinine-3 Antibody |
20-1734 |
Fitzgerald |
1 mg |
EUR 346.8 |
Description: Purified Polyclonal Cotinine-3 Antibody |
Cotinine-3 Antibody |
abx022796-1mg |
Abbexa |
1 mg |
EUR 844.8 |
|
Cotinine-4 Antibody |
abx022798-1mg |
Abbexa |
1 mg |
EUR 844.8 |
|
Cotinine ELISA Kit |
abx051430-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Cotinine ELISA Kit |
abx351101-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Cotinine ELISA Kit |
K4152-100 |
Biovision |
each |
EUR 848.4 |
Panbio™ COVID-19 Ag Rapid Test Device (Nasal) |
41FK11 |
Abbott |
25 Tests/Kit |
EUR 128 |
|
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19 |